| # | Side effect | Count |
|---|---|---|
| 0 | PSORIASIS | 504 |
| 1 | DRUG INEFFECTIVE | 240 |
| 2 | ARTHRALGIA | 195 |
| 3 | INTENTIONAL PRODUCT USE ISSUE | 180 |
| 4 | PSORIATIC ARTHROPATHY | 177 |
| 5 | FATIGUE | 174 |
| 6 | PRODUCT DOSE OMISSION ISSUE | 145 |
| 7 | DISEASE RECURRENCE | 139 |
| 8 | THERAPY INTERRUPTED | 139 |
| 9 | HEADACHE | 131 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | VACCINATION SITE DISCHARGE | 5 | 0.7143 |
| 1 | ANTITHROMBIN III ABNORMAL | 1 | 0.5000 |
| 2 | ACROKERATOSIS PARANEOPLASTICA | 4 | 0.4444 |
| 3 | VACCINATION SITE VESICLES | 5 | 0.2273 |
| 4 | VACCINATION SITE HAEMORRHAGE | 5 | 0.1389 |
| 5 | COLLAGEN-VASCULAR DISEASE | 8 | 0.1143 |
| 6 | HEAD AND NECK CANCER METASTATIC | 4 | 0.0952 |
| 7 | PYODERMA STREPTOCOCCAL | 2 | 0.0800 |
| 8 | MUCOCUTANEOUS CANDIDIASIS | 7 | 0.0753 |
| 9 | ENTHESOPHYTE | 3 | 0.0714 |